Navigation Links
AMICAS Appoints Joseph D. Hill to Its Board of Directors and Promotes Kevin C. Burns to Senior Vice President and Chief Financial Officer
Date:3/24/2008

Company reaffirms 2008 financial guidance

BOSTON, March 24 /PRNewswire-FirstCall/ -- AMICAS, Inc. (Nasdaq: AMCS), a leader in radiology and medical image and information management solutions, announced today that the board of directors has appointed Joseph D. Hill to AMICAS' board of directors while accepting his resignation as senior vice president and chief financial officer. In addition, the company has promoted Kevin C. Burns as senior vice president and chief financial officer. These changes will be effective April 4, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO )

"AMICAS is very appreciative of Joe's contributions. He is a very experienced and capable chief financial officer," said Stephen Kahane, MD, president, chief executive officer, and chairman of AMICAS. "Joe has provided tremendous financial leadership and he has been instrumental in helping position AMICAS for continued solid performance. We are excited to have Joe as a member of our board of directors."

Burns Promoted to Chief Financial Officer

"AMICAS has a very strong management team that will continue to guide the company," continued Dr. Kahane. "Kevin's extensive operational and financial management background, combined with his tenure as AMICAS' vice president of finance and corporate development, provides AMICAS with proven financial leadership. We look forward to Kevin's ongoing contributions to building a leading image and information management solutions company."

Burns brings more than 15 years of experience in finance and operations, across a variety of publicly traded high technology companies, to the position of chief financial officer. Burns joined AMICAS in 2004 and was most recently vice president of finance and corporate development, where he was responsible for corporate planning and analysis, commercial operations, and corporate development initiatives. Prior to joining AMICAS, Burns was a controller and responsible for financial planning and analysis at publicly traded NMS Communications, a solutions provider for mobile applications in wireless networks. Previously, Mr. Burns was director of corporate development at Demantra, Inc. and he has also held senior management positions in finance and strategic planning at MAPICS, Inc., a public software company that experienced significant growth and was ultimately sold to a multi-national company. He holds an MBA from the F.W. Olin Graduate School of Business at Babson College and a bachelor of science from Babson College.

2008 Guidance

AMICAS is reaffirming its previously provided guidance for 2008 with revenues expected to be between $52 million and $54 million, with pro-forma EBITDA expected to be between $1.0 million and $1.5 million, which is consistent with a net loss of approximately ($0.02) per share. EBITDA, a non- GAAP financial measure, refers to Net Income, adjusted for Amortization, Depreciation, Interest, and Stock Compensation expense.

A reconciliation of Net Income determined under GAAP to EBITDA is included below. Management believes that its EBITDA measurement, when viewed in addition to the Company's reported GAAP results, provides an additional meaningful measure of operating performance, enabling investors to more thoroughly evaluate current performance in comparison to past performance. This information will necessarily differ from comparable information that may be provided by other companies and should not be considered in isolation or as an alternative to the Company's operating and other financial information determined under GAAP.

Combining a market where imaging businesses continue to embrace automation as part of the response to the DRA with the combination of new product introductions already in progress, AMICAS expects 2008 bookings growth of between 10 to 20 percent. Bookings are defined as contractual commitments from customers for licenses, services, hardware, and maintenance/support.

About AMICAS, Inc.

AMICAS, Inc. (http://www.amicas.com) is a leader in radiology and medical image and information management solutions. The AMICAS(R) Vision Series(TM) products provide a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided with a fully integrated, hospital information system- independent PACS that features advanced enterprise workflow support and scalable design. Complementing the Vision Series product family is AMICAS Insight(TM) Solutions, a set of client-centered professional and consulting services that assist our customers with a well-planned transition to a digital enterprise.

Reconciliation of projected net loss to projected 2008 Projected

(in thousands) Lower Upper

EBITDA Range Range

Projected net loss $(1,350) $(850)

Interest income 3,000 3,000

Operating loss (4,350) (3,850)

Non-cash stock compensation expense 1,816 1,816

Depreciation and amortization 1,286 1,286

Amortization of software development costs 2,286 2,286

Projected EBITDA 1,037 1,537

CONTACT:

Aine Cryts, Marketing Communications Manager

617.779.7802

acryts@amicas.com


'/>"/>
SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
2. AMICAS Hosts Complimentary DRA Education Session Featuring Timothy Trysla
3. AMICAS to Present at William Blair & Company Small Cap Growth Stock Conference
4. AMICAS Schedules Third Quarter Earnings Call
5. Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider
6. Webcast Alert: AMICAS, Inc. Announces 3rd Quarter 2007 Earnings Conference Call
7. AMICAS Launches Vision Reach 2.0, a Tool to Help Radiology Businesses Grow
8. AMICAS Transforms Critical Results Notification with RadStream
9. AMICAS Solutions Closing the Loop in Radiology Communications
10. MedQuest Standardizes on AMICAS Vision Series PACS
11. AMICAS to Present at UBS Global Healthcare Services Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 02, 2016 , ... Metabolic Code ... to nutraceuticals and help doctors more efficiently manage their practice. Power2Practice is ... software platform for Integrative and Functional Medicine. , The Metabolic Code platform ...
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known ... for in a show called "Front Page". One of the forthcoming episodes examines mammogram ... rates have plummeted in large part due to early detection. Like any other disease, ...
(Date:12/4/2016)... ... December 04, 2016 , ... ... new attractive animation styles with unique displacement design elements," said Christina Austin - ... third designs. Choose from a variety of design styles that include both left ...
(Date:12/4/2016)... (PRWEB) , ... December 04, 2016 , ... Responsible dental ... One must brush properly to achieve optimal results. This important necessity inspired an inventor ... need for a way to ensure that people break or avoid bad techniques of ...
(Date:12/2/2016)... Phoenix (PRWEB) , ... December 02, 2016 , ... ... statewide documentary on the perils of heroin that was watched live by 1 ... national Alfred I. duPont-Columbia University Award. , ASU students at the Walter Cronkite ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... The U.S. Food and Drug Administration today ... the risk of cardiovascular death in adult patients with ... "Cardiovascular disease is a leading cause of death ... Jean-Marc Guettier , M.D., C.M., director of the Division ... Drug Evaluation and Research. "Availability of antidiabetes therapies that ...
(Date:12/2/2016)... in the ECG Cables And ECG Leadwires Market owing to ... devices. On the other hand, the Asia-Pacific ... rate during the forecast period. The market players ... plc ( Ireland ), Koninklijke Philips N.V. ( ... ( China ), held major share of the ...
(Date:12/2/2016)... 2016 According to a ... by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical ... Nephrology, Infectious Diseases) - Forecast to 2021" published ... USD 60.22 Billion in 2016. This market is ... during the forecast period (2016-2021) to reach USD ...
Breaking Medicine Technology: